2021
DOI: 10.1016/j.jddst.2021.102388
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and cytotoxicity evaluation of gemcitabine-tobacco mosaic virus conjugates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…The history of virology identified the first virus, named the tobacco mosaic virus, in 1892. [10][11][12][13][14] The viruses have kept evolving since then in virology literature by incorporating sophisticated microscopes. 15,16 The world has become like a global village, and surveillance of the emergence and reappearance of regional epidemics or global pandemics rapidly spread transmittable diseases.…”
Section: Introductionmentioning
confidence: 99%
“…The history of virology identified the first virus, named the tobacco mosaic virus, in 1892. [10][11][12][13][14] The viruses have kept evolving since then in virology literature by incorporating sophisticated microscopes. 15,16 The world has become like a global village, and surveillance of the emergence and reappearance of regional epidemics or global pandemics rapidly spread transmittable diseases.…”
Section: Introductionmentioning
confidence: 99%
“…PVNPs can protect these cargoes from degradation and deliver them, which is conducive to their continued role. PVNPs can load small molecule drugs such as MTO [ 55 ], phenanthriplatin [ 59 , 70 ], gemcitabine [ 71 ] and cisPt [ 72 ], increase their accumulation within the tumor tissue, and induce tumor cytotoxicity. For example, loading DOX by CPMV [ 56 ], RCNMV [ 53 ], JgCSMV [ 73 ], or the prodrug DOX by PhMV-based VLPs [ 74 ] significantly improved antitumor efficacy in vitro and in vivo.…”
Section: Therapeutic Agent Deliverymentioning
confidence: 99%
“…Therefore, various PVNPs have been developed and used for reducing these limitations. For example, loading mitoxantrone (MTO), a topoisomerase II inhibitor; phenanthriplatin, a cationic monofunctional DNA-binding platinum (II) complex; and gemcitabine, one of the nucleoside analog drugs, into tobacco mosaic virus (TMV) increased their accumulation within the tumor tissue and induced sufficient cytotoxicity toward MDA-MB-231, TNBC, and Michigan Cancer Foundation-7 (MCF7) cell lines [35,36]. In vivo MTO-TMV delivery in a mouse model of MDA-MB-231 xenografts reduced tumor growth, showing superior efficacy over free MTO [35].…”
Section: Small Molecule Drug Deliverymentioning
confidence: 99%